Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00403156
Status:
WITHDRAWN
Last Update Posted:
2015-12-31
First Post:
2006-11-22
Brief Title:
Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Sponsor:
Vitreous -Retina- Macula Consultants of New York
Organization:
Vitreous -Retina- Macula Consultants of New York
Organization Data
Organization:
Vitreous -Retina- Macula Consultants of New York
Class:
OTHER
Study ID:
FVF3989S
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Vitreous -Retina- Macula Consultants of New York
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Richard Spaide MD
Old Organization:
Vitreous Retina Macula Consultants of New York
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |